Random Dermatology MCQ - Type III dysbetalipoproteinemia

A 55-year-old fisherman presents with asymptomatic, waxy, yellow-orange papules coalescing into plaques on his neck and axillae. The lesions appear stuck-on and show a positive folded ear sign.

RANDOM DERMATOLOGY MCQS

9/23/20251 min read

worm's-eye view photography of concrete building
worm's-eye view photography of concrete building

A 55-year-old fisherman presents with asymptomatic, waxy, yellow-orange papules coalescing into plaques on his neck and axillae. The lesions appear stuck-on and show a positive folded ear sign. A skin biopsy reveals dermal deposition of lipid-laden macrophages. Which of the following is the most likely underlying metabolic abnormality?

A) Type I hyperlipoproteinemia
B) Type IIa hypercholesterolemia
C) Type III dysbetalipoproteinemia
D) Type IV hypertriglyceridemia
E) Type V mixed hyperlipidemia

Correct Answer: C) Type III dysbetalipoproteinemia

Explanation

Key Features of Eruptive Xanthomas in Type III Dysbetalipoproteinemia:

  1. Clinical Presentation:

    • Tuberoeruptive xanthomas: Yellow-orange papules/plaques on extensor surfaces (elbows, knees) and intertriginous areas.

    • "Folded ear" sign: Xanthomatous infiltration of the anthelix (pathognomonic for type III).

    • Palmar xanthomas: Orange-yellow streaks in palmar creases.

  2. Histopathology:

    • Foamy macrophages in the dermis with lipid deposition.

    • Perivascular inflammation may be present.

  3. Metabolic Defect:

    • Defective ApoE2 clearance of chylomicron/VLDL remnants → elevated IDL.

    • Lab findings: ↑↑ cholesterol + triglycerides, "broad beta band" on lipoprotein electrophoresis.

Why Not Other Options?

  • (A) Type I: Eruptive xanthomas (trunk/buttocks) + lipemia retinalis (LPL deficiency).

  • (B) Type IIa: Tendon xanthomas (Achilles/extensors), normal triglycerides.

  • (D) Type IV: Eruptive xanthomas (high TG only), no folded ear sign.

  • (E) Type V: Mixed eruptive + tuberous xanthomas, no palmar involvement.

Management:

  • First-line: Fibrates (gemfibrozil) to reduce IDL.

  • Statin adjunct: If LDL remains elevated.

  • Dietary: Low-fat, reduced alcohol.

Prognosis: High risk for premature atherosclerosis if untreated.